Indeed, our results showed that the level of exosomal LINC00265 and LINC00467 was elevated in the samples at first complete remission (CR), but not at the non-remission (NR) or partial remission (PR), indicating that the exosomal expression of LINC00265 and LINC00467 may be useful in remission assessment in AML patients receiving chemotherapy. This evidence concerns the gene LINC00265 and acute myeloid leukemia.